Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Canadian-under $3.00 Stock-Picking Challenge -- Ignore unavailable to you. Want to Upgrade?

To: Flea who wrote (5916)	1/12/2002 8:35:09 AM
From: Al Collard	Respond to of 11802

Hi Flea, Your in with J-v @$.15 for 66,666 shares. Chart for Jaguar International Equities, Inc: stockcharts.com[l,a]dacaniay[pb50!c20][vc60][iLa12,26,9!Ll14] From the chart of J we can see the stock is currently trading under all it's major MA's and has resistance @$.18 it's 20EMA. The chart indicators are bearish but the NR from Friday of a financing arrangement could be a sign of things to come. Good luck with this pick, ** Al

To: Flea who wrote (5916)	1/14/2002 6:16:07 PM
From: Al Collard	Read Replies (2) \| Respond to of 11802

J-v...in the news: Jaguar shareholders approve licence deal, name change Mon 14 Jan 2002 Mr. James Dishes reports CORPORATE UPDATE All the resolutions put before Jaguar International shareholders at its annual and special meeting of members held on Friday, Jan. 11, 2002, were adopted. Significantly, shareholders adopted a resolution that approves the option and licence agreement with NanoPharm AG of Germany to acquire a worldwide field of use licence to certain nanoparticle technologies for the treatment of brain cancer (reported in Stockwatch on Sept. 28, 2001). Shareholders also approved a resolution to change the name of the company to Advectus Life Sciences Inc.